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CONCISE COMMUNICATION

Short message service (SMS) reminders and real-time
adherence monitoring improve antiretroviral therapy
adherence in rural Uganda
Jessica E. Haberera,b, Angella Musiimentac, Esther C. Atukundac,
Nicholas Musinguzic, Monique A. Wyattb, Norma C. Wareb
and David R. Bangsberga,b,c,d
See related paper on pages 1287 and 1301
Objective: To explore the effects of four types of short message service (SMS) plus realtime adherence monitoring on antiretroviral therapy (ART) adherence: daily reminders,
weekly reminders, reminders triggered after a late or missed dose (delivered to patients),
and notifications triggered by sustained adherence lapses (delivered to patient-nominated social supporters).
Design: Pilot randomized controlled trial.
Methods: Sixty-three individuals initiating ART received a real-time adherence monitor
and were randomized (1 : 1 : 1): (1) Scheduled SMS reminders (daily for 1 month, weekly
for 2 months), then SMS reminders triggered by a late or missed dose (no monitoring
signal within 2 h of expected dosing); SMS notifications to social supporters for
sustained adherence lapses (no monitoring signal for >48 h) added after 3 months.
(2) Triggered SMS reminders starting at enrolment; SMS notifications to social supporters
added after 3 months. (3) Control: No SMS. HIV RNA was determined at 9 months.
Percentage adherence and adherence lapses were compared by linear generalized
estimating equations and Poisson regression, respectively.
Results: Median age was 31 years, 65% were women, and median enrolment CD4þ
cell count was 322 cells/ml 97% took once daily tenofovir/emtricitabine/efavirenz.
Compared to control, adherence was 11.1% higher (P ¼ 0.04) and more than 48-h
lapses were less frequent (IRR 0.6, P ¼ 0.02) in the scheduled SMS arm. Adherence and
more than 48-h lapses were similar in the triggered SMS arm and control. No differences
in HIV RNA were seen.
Conclusion: Scheduled SMS reminders improved ART in the context of real-time
monitoring. Larger studies are needed to determine the impact of triggered reminders
and role of social supporters in improving adherence.
Copyright ß 2016 Wolters Kluwer Health, Inc. All rights reserved.
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Introduction

unwillingness to have cellular reception confirmed at
home, and inability to provide informed consent.

Cellular phone technology is a promising tool for
antiretroviral therapy (ART) adherence support [1],
although findings have been mixed. Adherence improved
with weekly short message service (SMS) reminders in
Kenya [2,3] and twice weekly SMS reminders in Nigeria
[4], whereas no benefit was observed with weekly SMS
reminders in Cameroon [5] and India [6], or with SMS
reminders 5 days a week in Brazil [7].

Procedures
All study participants received a real-time adherence
monitor (Wisepill Technologies, Cape Town, South
Africa) and were followed for 9 months. Monitor openings
during periods of inadequate cellular reception were stored
for later transmission. Participants were given solar chargers
and sent an SMS to charge the monitor as needed.

Real-time adherence monitoring can be accomplished
through pill bottles that record a date-and-time stamp for
each opening, which is then transmitted over cellular
networks. It is the only monitoring approach that can
trigger an intervention precisely when needed. Two
recent studies assessed the combination of real-time
adherence monitoring with SMS reminders triggered by
late or missed doses. One in China showed an
improvement in overall adherence [8], whereas one in
South Africa did not [9], although the latter found fewer
sustained adherence lapses. SMS could also be used to
engage social support systems, which have been shown to
be important for ART adherence [10–12]; however, this
type of intervention has not been previously studied.
Given the variable results in the literature, we conducted a
pilot randomized controlled trial of multiple types of
interventions based on SMS and real-time adherence
monitoring to improve adherence among individuals
initiating ART in Uganda.

Methods
Setting
Participants were recruited from the Mbarara Regional
Referral Hospital (MRRH) in southwestern Uganda,
which cares for 10 000 HIV-positive individuals. The
region is largely rural and approximately one-quarter of
homes have electricity.
Participants
This study involved two types of participants: individuals
taking ART (‘study participants’) and their ‘social
supporters’. Inclusion criteria for study participants were:
being 18þ years, initiating ART, owning a personal cell
phone with reliable reception, willing and able to identify
one to two social supporters, and living less than 20 km
from MRRH (to facilitate participant follow-up).
Inclusion criteria for social supporters were: being 18þ
years, owning a personal cell phone with a reliable
reception, knowing the study participant’s HIV status,
living less than 20 km from MRRH, and reporting prior
provision of social support to the study participant (i.e.
instrumental support to attend clinic or motivational
support to take medicine). Exclusion criteria for both
participant types were: inability to use SMS,

A simple random number generator was used to determine
study arm assignments. The study coordinator informed
research assistants of the arm assignment at enrolment.
Participants were randomized 1 : 1 : 1 as follows:
(1) Scheduled SMS þ real-time adherence monitoring
(‘scheduled SMS arm’) – Study participants received an
SMS reminder daily for 1 month, then weekly for
2 months. For the next 6 months, study participants
received an SMS only if no signal was received from the
monitor within 2 h of the expected dosing time, and an
SMS notification was sent to one to two social
supporters if no signal was received for more than 48 h.
(2) Triggered SMS þ real-time adherence monitoring
(‘triggered SMS arm’) – For the whole 9 months, study
participants received an SMS only if no signal was
received from the monitor within 2 h of the expected
dosing time. For the latter 6 of the 9 months, an SMS
notification was sent to one to two social supporters if
no signal was received for >48 h.
(3) Real-time adherence monitoring only (called the
‘control’) – Study participants in this arm received
no SMS reminders.

Social supporters were encouraged to support the study
participant’s adherence, but were not given specific
guidance. All SMS content could be personalized; the
default message was ‘This is your reminder’. Scheduled
SMS were sent at participant-specified times.
Participants completed a questionnaire regarding sociodemographics, health, depression [13], food insecurity
[14], alcohol use [15], social support [16], and HIV stigma
[17]. HIV RNA was determined at months 3 and 9
(Cobas Taqman Test, Roche, Switzerland). Social
supporters were enrolled during month 3 to ensure
ongoing relationships when the SMS notifications began.
Qualitative interviews conducted during the study are
presented in a companion article [18].

Analysis
Assuming a standard deviation of 10%, we determined a
sample size of 63 would allow 84% power to detect an
increase in mean adherence from 80 to 90% for each arm
compared with control. Study participant characteristics
were compared across study arms with Fisher’s exact test
and the Wilcoxon rank-sum test. Our primary outcome
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participants. Reasons for exclusion were (multiple criteria
applied to some individuals):

of interest was adherence (calculated as the number of
monitor opening signals received divided by the number of
monitor opening signals expected, and capped at 100%).
Monitor openings by staff were removed. A secondary
dataset was created in which suspected technical difficulties
or monitor nonuse per participant report was censored.
Although subject to recall and social desirability biases, the
secondary dataset may decrease misclassification bias. In an
intention-to-treat analysis, percentage doses taken each
month were compared by linear generalized estimating
equations (GEEs); more than 48-h and more than 96-h
lapses in dosing were compared by Poisson GEE regression.
HIV RNA suppression (<100 copies/ml) was compared
among study arms by Fisher’s exact test. To compare
adherence with HIV RNA, we ran the rank-sum test for
median adherence among participants with suppressed
versus unsuppressed HIV RNA. Loss to follow-up was
defined as no contact or adherence data for 3 months.
Missing adherence data was considered as nonadherence;
HIV RNA was considered unsuppressed if no blood
sample was obtained. All analyses were conducted in Stata
(StataCorp., College Station, Texas, USA).

(1) Lived more than 20 km from MRRH: 75 (57%)
(2) No personal cell phone: 49 (37%)
(3) Not willing or able to name one to two social
supporters: 20 (15%)
(4) Unwilling to have cell reception tested at home: 6 (5%)
(5) Inability to provide informed consent: 3 (2%)
(6) Inadequate cellular reception: 2 (2%)
(7) Less than 18 years old: 1 (1%)

Twenty-one participants were assigned to the scheduled
SMS arm, 20 to the triggered SMS arm, and 21 to the
control. One participant was found to be HIV-negative
after randomization and disenrolled; data for this
participant were excluded from analysis. Forty-eight
individuals were identified as social supporters, of whom
45 enrolled; the three ineligible individuals lived more
than 20 km from MRRH. Follow-up concluded as
planned in June 2015.

Ethics
Human subject approval was obtained from Mbarara
University of Science and Technology, Uganda National
Council of Science and Technology, and Partners
Healthcare.

Fifty-eight (94%) study participants completed the study
with a median follow-up of 8.9 months [interquartile
range (IQR) 8.7–8.9]. Four study participants were lost
to follow-up (two in the triggered SMS arm, two in the
control). Forty-one social supporters completed the
study. One social supporter died, one was lost-to-followup, and two were disenrolled per the study participant’s
request.

Results

Participant characteristics are presented in Table 1. All
were similar among study arms with the exception of
female gender (71% in the schedule SMS arm, 35% in the
triggered SMS arm, 86% in the control; P ¼ 0.03).

Participant characteristics
Between September 2013 and October 2014, 195
individuals were screened to identify 63 eligible study

Table 1. Study participant and social supporter characteristics at enrolment.
Study participants (N ¼ 62)

Social supporters (N ¼ 45)
N (%) or median (IQR)

Female
Median age (years)
Education
None
Primary
Greater than primary
Able to read English or Runyankole
Median CD4þ cell count (cells/ml)
ART regimen
TDF-3TC-EFV
ZDV-3TC-NVP
Severe food insecurity
Depression
Hazardous alcohol use
Social support scoreb
Stigma scorec

40 (65%)a
30 (25–35)
5
36
21
60
309

(8%)
(58%)
(34%)
(97%)
(231–397)

60
2
23
30
14
3.1
3

(97%)
(3%)
(37%)
(48%)
(23%)
(2.8–3.4)
(2–5)

31 (69%)
35 (31–46)
3
22
20
43

14
1
6
3.1
0

(7%)
(49%)
(44%)
(96%)
n/a
n/a
n/a
(31%)
(2%)
(13%)
(2.6–3.7)
(0–1.25)

Social supporters were only enrolled for study participants in the intervention arms. ART, antiretroviral therapy; EFV, efavirenz; NVP, nevirapine;
TDF, tenofovir; ZDV, zidovudine; 3TC, lamivudine.
a
Female gender was noted to be different among the randomized study arms (71% in the schedule SMS arm, 35% in the triggered SMS arm, 86% in
the control; P ¼ 0.03). All other characteristics were similar among study arms.
b
This score ranges from 1 to 4, with 4 indicating high levels of social support.
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Table 2. Comparison of adherence by study arm over the 9-month study period.
Study arm

Percentage adherence
Median (IQR)
Mean (SD)
Intervention effect (P value)
Lapses in adherence
More than 48 h
Median (IQR)
Mean (SD)
Intervention effect (P value)
More than 96 h
Median (IQR)
Mean (SD)
Intervention effect (P value)

Scheduled SMS þ
real-time monitoring

Triggered SMS þ
real-time monitoring

Control (real-time
monitoring only)

92% (88–99)
91% (9)
11.1 (0.02)

84% (66–93)
79% (18)
0.7 (0.90)

90% (72–93)
79% (22)
ref

5 (1–11)
7 (8)
0.6 (0.02)

8 (4–16)
11 (10)
1.0 (0.80)

6 (3–19)
11 (11)
ref

1 (0–1)
1 (2)
0.3 (<0.001)

2 (0–6)
3 (3)
0.7 (0.23)

2 (1–3)
4 (5)
ref

Intervention effects for percentage adherence reflect the difference in mean adherence, whereas intervention effects for lapses in the real-time
monitoring signal indicate the incremental risk ratio. These results were found in the primary dataset in which only staff openings were censored.
Results for the secondary dataset, in which suspected technical difficulties and device nonuse were also censored, were similar. IQR, interquartile
range; SD, standard deviation. Significant values (P < 0.05) are bolded.

SMS
During the study, 3436 (63%) SMS were sent as planned
and 1935 (36%) were sent unnecessarily (i.e. the monitor
was opened, but no signal was received until after an SMS
had been sent). Forty-four (1%) SMS were not sent
because of technical challenges (e.g. network outages).
Adherence
Percentage adherence was 11.1% higher (P ¼ 0.02) and
more than 48-h and more than 96-h lapses were less
frequent [incremental risk ratio (IRR) 0.6, P ¼ 0.02 and
IRR 0.3, P < 0.001, respectively] in the scheduled SMS
arm compared with the control (Table 2). Adherence was
similar in the triggered SMS arm and control, although
the frequency of more than 96-h adherence lapses showed
a downward trend in the triggered SMS arm.
In the secondary dataset, 2% of participant-days were
censored for suspected monitor nonuse and 3% for
technical difficulties; no statistically significant differences
in the analysis were seen. No statistically significant
differences were seen when controlling for sex differences
among study arms.

HIV RNA suppression
HIV RNA was suppressed in 53 of 62 (85%) participants
at months 3 and 9, although only 47 participants were
suppressed at both time points. No statistically significant
differences in HIV RNA suppression were seen among
study arms (P ¼ 0.14); however, adherence correlated
with HIV RNA. At month 9, median adherence was
91 (IQR 82–96) for participants with suppressed HIV
RNA versus 57 (IQR 47–78) for those with unsuppressed HIV RNA (P < 0.001).

Discussion
In the context of real-time monitoring, daily and then
weekly scheduled SMS reminders starting at ART
initiation improved adherence compared with real-time
monitoring alone, whereas SMS reminders linked to late
or missed doses did not. Our findings confirm the positive
impact of fixed interval reminders in prior studies [2–4].
In one of these studies, daily reminders were not effective,
but weekly reminders were [3]; however, daily messages
were sent for 48 consecutive weeks, potentially causing
habituation. The decreasing frequency of SMS reminders
in this study may have avoided that phenomenon.
Although prior studies saw significant benefit in overall
adherence [8] and adherence lapses [9] with SMS linked
to real-time detection of late or missed doses, we did not.
Potential explanations include the overall high adherence
in this study and the small sample size. Additionally,
qualitative data from this study (presented separately) [18]
indicate that scheduled reminders were experienced as
supportive, whereas triggered reminders could be
received too late to be effective (i.e., after participants
were asleep).
The lack of definitive benefit from SMS notifications to
social supporters was surprising. Social support has been
shown previously to be important for ARTadherence (e.g.,
via access to resources and reduced stigma) [10–12].
Detailed assessment of the support provided and relationship dynamics between study participants and social
supporters will be important to understand this finding.
Similar viral suppression among study arms is consistent
with the two other studies of real-time adherence
interventions [8,9]. Importantly, this study was not
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powered for differences in viral suppression. It is possible
that differences in virologic outcomes could be seen in a
larger study with longer follow-up.
This study has important limitations. Real-time monitoring in the control group likely has its own intervention
effect and may have limited the ability to detect
intervention effects from SMS in the other study arms
– a phenomenon explored in the separately presented
qualitative findings [18]. Additionally, 37% of screened
participants were excluded because they lacked access to a
personal cell phone. Participants may have had relatively
high socioeconomic status, thus limiting generalizability.
In summary, we found that scheduled SMS significantly
increased adherence in individuals initiating ART in
Uganda. The technology employed for real-time
adherence monitoring and accompanying SMS was
successfully implemented despite limited resources.
Future work should assess costs of this technology to
inform scalability. Studies are also needed to determine
the benefits associated with SMS alone versus SMS tied to
real-time adherence monitoring.
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